The Latest Breaking News from ELV

Amid the Fed’s hawkish stance to keep raising interest rates in 2023 and weakening economic outlook, a recession looks imminent next year. Amid ongoing market uncertainties, investors should focus on their long-term strategies. Therefore, fundamentally sound dividend-paying stocks, Coca-Cola Company (KO), Elevance Health (ELV), and Weis Markets (WMK) could be…

Despite widespread macro headwinds, the U.S. economy and its tight labor market look resilient enough to sustain possible downturns in the upcoming term. Moreover, as the stock market is expected to make a comeback soon, Comcast (CMCSA), Elevance Health (ELV), and Waste Management (WM) could be no-brainer stocks to buy…

The stock market continues to be a challenging environment with rising rates a potent headwind. So far, the economy has been stable enough so that earnings growth has not contracted, but this is unlikely to persist the longer the Fed stays hawkish. This article discusses characteristics of stocks that are…

The stock market has given back the bulk of its gains following a stronger than expected inflation print. Amid these challenging circumstances, investors should consider high-quality, defensive stocks like Elevance Health (ELV) and Northrop Grumman (NOC).

Someone with a lot of money to spend has taken a bullish stance on Elevance Health (NYSE:ELV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Despite the market’s massive decline since the beginning of the year on concerns over macroeconomic and geopolitical issues, Elevance Health (ELV), Waste Management (WM), and Coca-Cola FEMSA (KOF) continued to soar and are currently trading above their moving averages. Since these stocks are expected to maintain their momentum based on…

Amid the ongoing economic turbulence, sectors like healthcare, which enjoy inelastic demand and can pass on an increase in cost to end consumers, make a good investment option. Moreover, rising chronic diseases, an aging population, and increased healthcare spending should drive the sector’s growth. So, it could be the right…

Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on.

Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on.